Literature DB >> 16531750

Genetic variants predisposing to cardiovascular disease.

Sophie Visvikis-Siest1, Jean-Brice Marteau.   

Abstract

PURPOSE OF REVIEW: The goal of this review is to provide an update on the most recent and relevant findings in the area of genotype-phenotype associations as well as the relationships between genetic factors and cardiovascular disease risk markers and events. In addition, emphasis will be placed on the methodological problems associated with studying the genetics of complex disorders, specifically cardiovascular diseases. RECENT
FINDINGS: Genes associated with cardiovascular disease predisposition have been examined, including traditional cardiovascular disease candidate genes, such as ACE, AGT, eNOS, PON and MTHFR, new loci that have recently been added to the growing list of cardiovascular disease candidate genes (i.e. MEF2A, ALOX5, LTA, APOM, PDE4D), and genes that have been shown to be at the intersection of several age-related disorders through interaction with one another or with environmental factors (i.e. APOA5, APOE, PPARgamma, LPL and LIPC).
SUMMARY: During the last year, tremendous effort has been made in elucidating new genes associated with cardiovascular disease predisposition. For the most part, however, major breakthroughs have not been made, primarily due to the poor replication of results among studies, as a consequence of poor experimental design. Nevertheless, we have increased our understanding of the complexity of cardiovascular disease and the relevance of gene-environment interactions as the ultimate drivers of the individual predisposition to the disease. It is essential, therefore, that present and future genetic studies in this area take into consideration the inclusion of high-quality environmental data in the analytical process to test the clinical usefulness of a genetic marker as a risk predictor.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16531750     DOI: 10.1097/01.mol.0000217895.67444.de

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  17 in total

1.  Usefulness of factor V Leiden mutation testing in clinical practice.

Authors:  Ellen Ø Blinkenberg; Ann-Helen Kristoffersen; Sverre Sandberg; Vidar M Steen; Gunnar Houge
Journal:  Eur J Hum Genet       Date:  2010-03-24       Impact factor: 4.246

2.  Can we learn more about the etiology of cardiovascular disease?

Authors:  Lewis H Kuller
Journal:  Eur J Epidemiol       Date:  2007-02-28       Impact factor: 8.082

Review 3.  Racial differences in nitric oxide-dependent vasorelaxation.

Authors:  Eugenia Mata-Greenwood; Dong-Bao Chen
Journal:  Reprod Sci       Date:  2008-01       Impact factor: 3.060

Review 4.  The Neurobiology and Age-Related Prevalence of the ε4 Allele of Apolipoprotein E in Alzheimer's Disease Cohorts.

Authors:  Amy L Heffernan; Cameron Chidgey; Po Peng; Colin L Masters; Blaine R Roberts
Journal:  J Mol Neurosci       Date:  2016-08-06       Impact factor: 3.444

5.  Genetic polymorphisms in fatty acid metabolism genes and colorectal cancer.

Authors:  M Crous-Bou; G Rennert; R Salazar; F Rodriguez-Moranta; H S Rennert; F Lejbkowicz; L Kopelovich; S M Lipkin; S B Gruber; V Moreno
Journal:  Mutagenesis       Date:  2012-03       Impact factor: 3.000

Review 6.  Racial disparities in cardiovascular disease risk: mechanisms of vascular dysfunction.

Authors:  R Matthew Brothers; Paul J Fadel; David M Keller
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-08-09       Impact factor: 4.733

7.  Determination of single-nucleotide polymorphism in the proximal promoter region of apolipoprotein M gene in coronary artery diseases.

Authors:  Lu Zheng; Guanghua Luo; Xiaoying Zhang; Jun Zhang; Jiang Zhu; Jiang Wei; Qinfeng Mu; Lujun Chen; Peter Nilsson-Ehle; Ning Xu
Journal:  Int J Gen Med       Date:  2009-12-29

8.  Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: results of the ICARIA genetic sub-study.

Authors:  María-José Ariza; Miguel-Angel Sánchez-Chaparro; Francisco-Javier Barón; Ana-María Hornos; Eva Calvo-Bonacho; José Rioja; Pedro Valdivielso; José-Antonio Gelpi; Pedro González-Santos
Journal:  BMC Med Genet       Date:  2010-04-29       Impact factor: 2.103

9.  Apolipoprotein e gene polymorphism and its effect on plasma lipids in arteriosclerosis.

Authors:  P D Zende; M P Bankar; P S Kamble; A A Momin
Journal:  J Clin Diagn Res       Date:  2013-10-05

10.  Gene polymorphisms in association with emerging cardiovascular risk markers in adult women.

Authors:  Amy Z Fan; Ajay Yesupriya; Man-huei Chang; Meaghan House; Jing Fang; Renée Ned; Donald Hayes; Nicole F Dowling; Ali H Mokdad
Journal:  BMC Med Genet       Date:  2010-01-15       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.